• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身炎症标志物在上皮性卵巢癌中的预后和预测价值

Prognostic and Predictive Value of Systemic Inflammatory Markers in Epithelial Ovarian Cancer.

作者信息

İdrisoğlu Cem, Muğlu Harun, Hamdard Jamshid, Açıkgöz Özgür, Olmusçelik Oktay, Müezzinoğlu Bahar, Ölmez Ömer Fatih, Yıldız Özcan, Bilici Ahmet

机构信息

Department of Internal Medicine, Faculty of Medicine, Medipol University, Istanbul 34214, Turkey.

Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34214, Turkey.

出版信息

Medicina (Kaunas). 2025 Feb 22;61(3):380. doi: 10.3390/medicina61030380.

DOI:10.3390/medicina61030380
PMID:40142191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944068/
Abstract

Epithelial ovarian cancer (EOC) remains a significant global health challenge. While traditional prognostic factors are well established, emerging biomarkers continue to gain attention. This retrospective study evaluated the impact of systemic inflammatory markers on progression-free survival (PFS) and overall survival (OS) in 154 EOC patients. Pre-treatment neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and systemic inflammatory index (SII) were calculated and categorized into low and high groups. Univariate and multivariate analyses were conducted to identify independent prognostic factors, while logistic regression analysis was used to determine predictors of platinum resistance. In the univariate analysis, elevated NLR and PLR were associated with poorer PFS and OS. However, these markers did not maintain statistical significance in the multivariate analysis. Although SII demonstrated a trend toward worse outcomes, it did not reach statistical significance. Histopathological type, PLR, and surgical approach were identified as independent predictors of platinum resistance. Our findings indicate that systemic inflammatory markers may hold prognostic value in EOC; however, further validation through larger prospective studies is necessary.

摘要

上皮性卵巢癌(EOC)仍然是一项重大的全球健康挑战。虽然传统的预后因素已得到充分确立,但新兴的生物标志物仍在不断受到关注。这项回顾性研究评估了全身炎症标志物对154例EOC患者无进展生存期(PFS)和总生存期(OS)的影响。计算了治疗前的中性粒细胞/淋巴细胞比值(NLR)、血小板/淋巴细胞比值(PLR)和全身炎症指数(SII),并将其分为低分组和高分组。进行单因素和多因素分析以确定独立的预后因素,同时使用逻辑回归分析来确定铂耐药的预测因素。在单因素分析中,升高的NLR和PLR与较差的PFS和OS相关。然而,这些标志物在多因素分析中未保持统计学意义。虽然SII显示出预后较差的趋势,但未达到统计学意义。组织病理学类型、PLR和手术方式被确定为铂耐药的独立预测因素。我们的研究结果表明,全身炎症标志物可能在EOC中具有预后价值;然而,需要通过更大规模的前瞻性研究进行进一步验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/f159c612412b/medicina-61-00380-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/28537a57aae1/medicina-61-00380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/ee4eeb86c438/medicina-61-00380-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/14ef7effcff2/medicina-61-00380-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/2004cec024ff/medicina-61-00380-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/f159c612412b/medicina-61-00380-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/28537a57aae1/medicina-61-00380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/ee4eeb86c438/medicina-61-00380-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/14ef7effcff2/medicina-61-00380-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/2004cec024ff/medicina-61-00380-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b880/11944068/f159c612412b/medicina-61-00380-g005.jpg

相似文献

1
Prognostic and Predictive Value of Systemic Inflammatory Markers in Epithelial Ovarian Cancer.全身炎症标志物在上皮性卵巢癌中的预后和预测价值
Medicina (Kaunas). 2025 Feb 22;61(3):380. doi: 10.3390/medicina61030380.
2
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测接受铂类化疗的上皮性卵巢癌患者的化疗反应及预后。
Cancer Biomark. 2016 Jun 7;17(1):33-40. doi: 10.3233/CBM-160614.
3
Predictive value of preoperative systemic immune-inflammation index and prognostic nutrition index in patients with epithelial ovarian cancer.术前全身免疫炎症指数和预后营养指数对上皮性卵巢癌患者的预测价值。
J Ovarian Res. 2025 Mar 7;18(1):45. doi: 10.1186/s13048-025-01631-4.
4
Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis.全血细胞炎症参数能否为上皮性卵巢癌的预后提供依据?——生存分析。
J Ovarian Res. 2019 Feb 11;12(1):16. doi: 10.1186/s13048-019-0491-7.
5
Prognostic Value of The Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Platelet Count for Platinum-Sensitive Recurrent Epithelial Ovarian Cancer.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及血小板计数对铂类敏感复发性上皮性卵巢癌的预后价值。
Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3765-3771. doi: 10.31557/APJCP.2023.24.11.3765.
6
Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line.一线治疗晚期卵巢癌患者的全血细胞计数获得的全身炎症反应指标的预后价值。
Clin Transl Oncol. 2024 Dec;26(12):3211-3217. doi: 10.1007/s12094-024-03523-3. Epub 2024 Jun 10.
7
Pan-immune-inflammation value: a new prognostic index in epithelial ovarian cancer.全身性免疫炎症指数:上皮性卵巢癌的一种新的预后指标。
BMC Cancer. 2024 Aug 26;24(1):1052. doi: 10.1186/s12885-024-12809-2.
8
Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review.免疫检查点抑制剂治疗胃癌患者中炎症标志物 NLR、PLR 和 LMR 的预后价值:荟萃分析和系统评价。
Front Immunol. 2024 Jul 10;15:1408700. doi: 10.3389/fimmu.2024.1408700. eCollection 2024.
9
Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.系统炎症标志物在卵巢癌中的预后价值:一项符合 PRISMA 原则的荟萃分析和系统评价。
BMC Cancer. 2018 Apr 18;18(1):443. doi: 10.1186/s12885-018-4318-5.
10
Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.患者炎症状态和 CD4+/CD8+上皮内肿瘤淋巴细胞浸润是高级别浆液性卵巢癌结局的预测因素。
Gynecol Oncol. 2018 Oct;151(1):10-17. doi: 10.1016/j.ygyno.2018.07.025. Epub 2018 Aug 2.

本文引用的文献

1
Additional value of Doppler ultrasound to B-mode ultrasound in assessing for uterine intracavitary pathologies among perimenopausal and postmenopausal bleeding women: a multicentre prospective observational study in Vietnam.经阴道超声联合多普勒超声在评估围绝经期及绝经后阴道出血患者宫腔内病变中的应用价值:越南多中心前瞻性观察研究。
J Ultrasound. 2023 Jun;26(2):459-469. doi: 10.1007/s40477-022-00732-w. Epub 2022 Oct 25.
2
Ultrasound-based radiomics for predicting different pathological subtypes of epithelial ovarian cancer before surgery.基于超声的影像组学预测术前上皮性卵巢癌的不同病理亚型。
BMC Med Imaging. 2022 Aug 22;22(1):147. doi: 10.1186/s12880-022-00879-2.
3
Prognostic value of pre-operative systemic immune-inflammation index and platelet to lymphocyte ratio in peritoneal carcinomatosis of ovarian origin.
术前全身免疫炎症指数和血小板与淋巴细胞比值对卵巢来源腹膜癌转移的预后价值。
Surg Oncol. 2022 Jun;42:101750. doi: 10.1016/j.suronc.2022.101750. Epub 2022 Mar 30.
4
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy.中性粒细胞与淋巴细胞比值及化疗反应评分作为新辅助化疗治疗卵巢癌患者的预后标志物。
J Ovarian Res. 2021 Nov 1;14(1):148. doi: 10.1186/s13048-021-00902-0.
5
Artificial intelligence in gynecologic cancers: Current status and future challenges - A systematic review.人工智能在妇科癌症中的应用:现状与未来挑战——系统评价。
Artif Intell Med. 2021 Oct;120:102164. doi: 10.1016/j.artmed.2021.102164. Epub 2021 Sep 3.
6
Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer.新辅助化疗期间中性粒细胞与淋巴细胞比值降低作为晚期卵巢癌的预测和预后标志物
Diagnostics (Basel). 2021 Jul 20;11(7):1298. doi: 10.3390/diagnostics11071298.
7
The Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Predicting Response to Platinum-based Chemotherapy for Epithelial Ovarian Cancer.血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值预测上皮性卵巢癌铂类化疗反应的价值。
Asian Pac J Cancer Prev. 2021 May 1;22(5):1561-1566. doi: 10.31557/APJCP.2021.22.5.1561.
8
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.炎性指标作为预测铂类敏感性和复发性上皮性卵巢癌患者预后的因素:一项 MITO24 回顾性研究。
Sci Rep. 2020 Oct 23;10(1):18190. doi: 10.1038/s41598-020-75316-x.
9
Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.系统免疫炎症指数对妇科和乳腺癌患者预后预测的荟萃分析。
World J Surg Oncol. 2020 Aug 7;18(1):197. doi: 10.1186/s12957-020-01974-w.
10
Elevated platelet lymphocyte ratio is a poor prognostic factor in advanced epithelial ovarian cancer.血小板淋巴细胞比值升高是晚期上皮性卵巢癌的不良预后因素。
J Gynecol Obstet Hum Reprod. 2021 Jun;50(6):101849. doi: 10.1016/j.jogoh.2020.101849. Epub 2020 Jun 30.